Frederick County Biotech Community

Everything Biotech in Frederick County, Maryland

Archive for May, 2009

My Delight, but a Germophobes Nightmare

Posted by Jim H on May 29, 2009

I am always (perhaps too much) scanning the blogosphere for anything related to FredCoBio news.  This story I predict will make the Network news tonight or maybe tomorrow.

The entire article is published in Science (and will require a paid subscription to view your tax dollars at work), but ther have been a number of AP stories circulating on the blogesphere today. You can read the whole story at ScienceNOW:

Your Body Is a Wonderland … of Bacteria

By Stephanie Pappas
ScienceNOW Daily News
28 May 2009

Where can you find your skin’s most diverse community of bacteria? Not in a sweaty armpit or linty belly button. According to a new survey of the bacterial ecosystem that covers us, the diversity hot spot of the body’s exterior is the forearm. And the surprises don’t end there.

Microbes that live in and on our bodies outnumber our own cells 10 to one, but researchers have only recently begun to catalog the residents on our skin. Traditionally, scientists identified human skin bacteria by swabbing volunteers and culturing the samples, but those results skewed toward microbes that grow well in the lab. Thanks to ever-evolving gene-sequencing technology, scientists can now use microbial RNA to identify organisms. With these techniques, researchers have found an unexpectedly wide variety of bacteria on human skin (Science, 23 May 2008, p. 1001). But no one had ever systematically compared bacterial colonies from different areas on the human body.

To do so, scientists from the National Human Genome Research Institute in Bethesda, Maryland, recruited 10 volunteers and asked them to wash with mild soap for 1 week. Then, after 24 hours without bathing, the volunteers arrived at the lab, where researchers swabbed and scraped their skin in 20 places–everywhere from the nostril to the navel to that bane of low-rise jeans aficionados, the gluteal crease. The team analyzed ribosomal RNA from the samples and classified the microbes based on their genomes.

The researchers found about 1000 species total, which were fairly consistent from person to person; it turns out we all have similar tenants in our noses and on our backs. The number suggests that our skin is as variegated as our guts, which house anywhere from 500 to 1000 bacterial species. The team also found vast differences across the skin, according to the study published in tomorrow’s issue of Science. Contrary to what acne-prone teenagers might expect, oily areas such as the forehead and scalp are actually less diverse than dry areas such as the forearm (though one is enough for grief: Propionibacterium acnes thrives in oily spots). The most barren region was behind the ear, with a median diversity of 15 species. In comparison, the forearm teemed with a median 44 species. A follow-up with five of the volunteers months later found that bacterial makeup changed little over time.

The link to FredCoBio is simple. Alice Y. and I worked together in at Molecular Diagnostic Division of Life Tech, which is now known as Digene/Qiagen.  She used to give us so many clothes passed down from her daughter, Rachel, to our oldest (now 20, yikes!).  And Bob B. is an original BRL guy who lives in Frederick.  I remember his wife worked the cash register at Martins on 7th street when we used to live in the city.  Anyway, they are both at NHGRI now, along with a number of other former Life Tech people.

Pretty cool research and yet another deep tie into the FredCoBio community.

Posted in Genetics, Government Funded research, Molecular Biology, Nature, News, prokaryotic | 1 Comment »

Opportunities Abound!

Posted by Jim H on May 28, 2009

A couple of quick notes as I procrastinate finilizing Grant application and cell culture duties.

Some really cool news from International Stem Cells came out yesterday.  From their web site:

WEDNESDAY, MAY 27, 2009

International Stem Cell Corporation Reports Positive Pre-Clinical Trial Results From Human Corneal Epithelial Cells

International Stem Cell Corporation (OTCBB:ISCO), the first company to perfect a method of creating human “parthenogenetic” stem cells from unfertilized eggs, has received positive early results from animal trials designed to improve photorefractive keratectomy (PRK), a form of corrective laser eye surgery that offers an improved alternative to LASIK.

PRK is generally thought to be safer and produce better long-term results than LASIK, but has not been used as frequently because of patient discomfort following surgery and a longer healing time. By combining ISCO’s human corneal cells with a proprietary surgical device developed by Paul H. Chen, M.D., who is conducting the trials, ISCO and Dr. Chen believe that cellular enhanced PRK can replace LASIK for many of the hundreds of thousands of patients who now use LASIK.

The first stage animal trials just completed demonstrated that ISCO’s corneal cells manufactured by ISCO’s subsidiary, Lifeline Cell Technology, encouraged corneal-defect healing in the animals. The trials are the first step toward gaining Food and Drug Administration (FDA) approval to test the efficacy of using ISCO’s cells to improve healing after corneal surgery, and could result in the first FDA approved use of human cells produced by ISCO.

Jeffrey Janus, President of ISCO and CEO of Lifeline, noted that “The cells used in these trials are derived from donated human tissue processed using proprietary techniques devised by ISCO’s subsidiary, Lifeline Cell Technology. However, ISCO’s parthenogenic stem cells can also produce human corneal cells. Corneal cells derived from ISCO’s parthenogenetic stem cells may provide a consistent and reliable source of corneal cells that could eliminate entirely the need for donated human tissues.”

This work is being done in collaboration with Dr. Chen, who has developed the cell transfer technology. Dr. Chen is an eye surgeon at North County Laser Eye Associates, and he is on staff at Scripps Memorial La Jolla and Scripps Encinitas Hospitals.

For more news and information on International Stem Cell Corporation please visit www.IRGnews.com/coi/ISCO where you can find the CEO’s video, a fact sheet on the company, investor presentations, and more

Maybe those of you who aren’t in the Biotech field don’t know how important it is to have “preclinical” data, which allows you to apply to the FDA for permission to run clinical trials. Your preclinical data had better be air tight and good.  Of course, the material was made by LifeLine in Walkersville, so it must be good. And for the sake of full disclosure and shameless self promotion, I am providing processed tissues for some other things that LifeLine is doing and I want them to do well.  Rumor has it they’ve installed additional, temporary space.  So all you people that I have telling to pay attention to little LLCT and ISCO, pay attention.

In other news, I was “tipped off” that a new RFP was posted on the SAIC-Frederick web site.  This is a pretty big one, but you’re going to need animal facilities. You can find the whole SOW and all the required documents  HERE, but this is the meat of it:

Solicitation No. S09-159  GLP Safety Testing of Vaccines Developed by Vaccine Research Center (VRC) Manufactured for Clinical Trial Use

Due date June 30, 2009

Perform GLP safety studies suitable for submission to the FDA for support of an IND application.

o Confirm AAALAC accreditation prior to initiating the study

o Work with the VRC to develop and finalize protocols. The VRC and the Subcontractor will sign off on the protocol and retain a copy

o Purchase and quarantine of suitable animals as specified in the protocol

o Housing of animals (1 animal per cage), test animals and control animals in separate rooms

o Administer injections of vaccine as directed in study protocol

o With VRC’s help, acquire and become trained to use Biojector and any other specialized injection devices

o Provide clinical evaluation and assess other measurements of health as specified in the protocol

o Euthanize animals and perform a gross necropsy in accordance with study protocol

o Collect blood and tissue from animals; send aliquot of blood to VRC for immune analysis and send tissues for other analysis as directed by VRC

o Run clinical chemistry and hematology tests as specified in protocol

o Run biodistribution studies as specified in protocol

o Analyze histopathology of preserved tissues as specified in the protocol

o Perform statistical analyses of test results and provide updated historical data for gender-matched unimmunized or placebo-controlled animals for comparison as specified by the protocol

o Audit test results

o As appropriate, investigate deviations of the protocol, procedures, or unexpected test results (e.g. moribund or found-dead animals) and report such investigations to VRC staff in a timely fashion.

o Provide unaudited interim, unaudited, and audited, signed final report as indicated in the protocol

• Interim clinical observations and measurements via email on a bi-weekly basis as indicated in the protocol. Interim (“unaudited”) report transmitted electronically to Project Coordinator and the VRC Project Lead (contact information listed below)

• Final report – One hard copy of this report can be sent to the VRC Project Lead and an electronic pdf version can be provided to Project Coordinator.

I hope they get as many interested parties as the last request, but haveing GLP animal facilities may make it tough.

Posted in Awards and recognition, Business, Expansion, Funding Available, Government Funded research, News, Public/Private Companies, Rants, Rumors, Stem Cells, Vaccines | Leave a Comment »

Exciting News: MdBio’s Golf Tourney is Back!

Posted by Jim H on May 27, 2009

Yes, it’s true. After a long hiatus, the MdBio Golf Tournament is returning to Whiskey Creek in June!

Picture I took from 18th Tee box in 2007

Picture I took from 18th Tee box in 2007

You can find all of the details HERE:

What: Driving Towards a Difference Golf Tournament

Where: Whiskey Creek Golf Club, Ijamsville, MD

When: Thursday, June 25, 2009

8AM – registration 9AM – shotgun start

Who: UMBI Foundation MdBio Foundation

Last year, UMBI raised enough proceeds to provide enhanced science education to over 1,000 student and teachers throughout the State of Maryland. Without this funding, they would not have had access to hands-on science learning. This year, we are joining MdBio Foundation, Inc. and hope to raise increased funds to benefit additional students across the state.

Our organizations are working to respond to the statewide need for more Science, Technology, Engineering & Mathematics (STEM) educational programming thorough existing and planned programs. Your tax-deductible support will help continue these mobile laboratory and equipment loan programs throughout the state of Maryland. Funds raised by this tournament will directly support a unique alliance of two Maryland organizations working to improve science education in Maryland: UMBI and MdBio Foundation’s education and outreach programs, including the mobile bioscience laboratory MdBioLab and the equipment loan program LoanerLab.

So aside from being a great, fun event  for a good cause this is also a place to get some business done!  I met a future partner one year and played with an old acquaintance the year before, who just happened to be former Director of NIH’s Stem Cell Repository.

Posted in Events | Leave a Comment »

Did I forget to mention that LifeTech is expanding in Frederick?

Posted by Jim H on May 26, 2009

I read yet another story in an out of town publication about the expansion at LifeTech in Frederick.

I case you missed it Joe Donegan announced this at the last BioBeers and I could have broken the whole to wide open.

So that’s two News stories I scooped at BioBeers that I haven’t broken.  The other was, of course, the Bruce Ivins’ suicide.

Anyways, here’s a link and nice story from GlobeSt.com (I sworwe I had seen this story inthe Gazette or Fred News-Post, but can’t find the story in either of them):

Life Technologies has inked a lease to occupy an entire industrial/flex building here owned by J&N Properties. The 56,438-square-foot lease is a ten-year term for the biotech company, which also plans to expand the building for pharmaceutical distribution, according to Chad Tyler of Tyler Donegan Real Estate. Tyler, along with Joseph Donegan represented the landlord in the transaction. CBRE’s David Palank and Frank Graybeal repped the tenant.
The building, located at 7311 Governor’s Way, had been vacant, Tyler tells GlobeSt.com. “Life Technologies will be spending about $1.5 million to renovate it,” he says. The asking rate for the building had been $7.25 per square foot, triple net.

From what I heard, the plans are to build out the former PGC Scientific space into clean rooms and state of the art distribution facilitys for cGMP production of therapeutic (presumably cell-based) products.

If this is true, then Frederick County will likely be the largest producer of mammailan cell culture therapeutic productss on the Earth, combined with the Lonza-Walkersville site.

And a really interesting story in the Washington post about how the DC area is the Center of the Stem Cell Universe, or at least the most desirable

College Graduates Flock to DC Area

The Associated Press: Tuesday, May 26, 2009; 7:21 AM

“The Washington area is attracting recent college graduates because the chances of landing a job remain high despite the economic downturn, experts said.
The area is “adding jobs in [service-providing industries] and in health care and in the federal sector,” said George Mason University economist Stephen Fuller. “And the jobs we’re losing in the region,” such as construction and retail sales, “tend not to be college graduate-type jobs.”

Posted in Business, Expansion, Jobs, Molecular Biology, News, Public/Private Companies, Rumors | Leave a Comment »

We’re Baack!

Posted by Jim H on May 22, 2009

Sorry about the long break the past couple of weeks.  I have been busy on a number of fronts.  Last week I went to US Pharmacopia HQ in Rockville to participate in the “Cell, Gene and Tissue therapies Expert Committee meeting #7″ .  It was quite eye opening, although somewhat structured.  IMG00061

This week I have dedicated myself to getting my MTTF Grant application completed.   I spent a good part of the day on Thursday last week working with my collaborators at the FDA to get the project defined in a bit more detail. The first pass is done, but the application needs to be reviewed and submitted.  Last week I was busy, busy.  On Wednesday I attended the BioEspaña program as a part of the Hopkins Biotech Network in MoCo.  It was very informative and interesting.  I know España is not the center of stem cell research in the universe (like we are here in FredCoBio), but I was very impressed with the amount of activity going on in different regional Biotech clusters.  Hopefully, I’ll have a chance to work with BTI Biotechnology Institute on some of their stem cell work.  Heck, any chance for a company paid trip to the Basque region would be fine with me.

Friday was the Frederick County Chamber of Commerce Annual Golf Scramble at Musket Ridge.

Speaking of the Chamber, I’ll be presenting the Social Media Conference session entitled

“Beyond Facebook & Twitter:  Niche networks, new platforms, mobile web, and the future of social media for business.”  That’ll be a mouthful.

More details here:

PDF registration form – including full conference schedule & list of presenters:

http://bit.ly/fredsmc

Online calendar & registration – members must login for discounted pricing:

http://bit.ly/fredsmc-web

Official Twitter tag, for viewing online discussions about this conference:

#fredsmc http://search.twitter.com/search?q=%23fredsmc

I didn’t get much Biotech business done on the golf course, but was fortunate to sit with Larry Arthur of SAIC-Frederick at the lunch afterward.  Yet another BioBeers fan added to the roster!

Speaking of SAIC-Frederick, I may have stirred up a bit of “fun” with my FedBizOps post a couple weeks back.  We sure did overwhelm the Procurement folks with more responses than they expected.  In case you didn’t read the comment, there is now a link Directly on SAIC-Frederick’s web site: http://www.ncifcrf.gov/bizopps/rfps.asp.  Bookmark it and keep an eye on it.  I’ll continue to try to find out more about how to get FredCoBio companies first in line for landing some of these prime contracts.

In Other SAIC-Frederick news (and I apologize because I got this on May 13th), a Press Release:

SAIC-Frederick, Inc. and Sensor Technologies Collaborating to Understand Complex Protein Interactions in Cancer

FREDERICK, Md., May 13, 2009 — SAIC-Frederick Inc., a wholly owned subsidiary of Science Applications International Corporation (SAIC) [NYSE: SAI], and Sensor Technologies Inc. of Shrewsbury, Mass., have signed a collaboration agreement to begin integrated studies of complex protein interactions involved in cancer and other diseases.

The agreement is part of the National Cancer Institute’s Advanced Technology Partnerships Initiative, which aims to further NCI’s mission by speeding the translation of research discoveries into new treatments for cancer and AIDS. SAIC-Frederick, as prime contractor for the National Cancer Institute at Frederick, is facilitating these partnerships for the government.

The collaboration will involve proteomics and imaging studies to advance the understanding of complex structural interactions and binding kinetics of proteins in cells and in cancer disease processes.

The Optical Microscopy and Analysis Laboratory (OMAL) and Protein Chemistry Laboratory (PCL) at SAIC-Frederick, together with Sensor Technologies, will begin integrated studies to assess the dynamics of fluorescence-tagged molecules utilizing Sensor Technologies’ newly launched Fluorescence Correlation Spectroscopy (FCS) platform—“QuantumXpert™.”

Studies will also include integration with in vivo microscopy techniques in OMAL with the goal of developing dynamic, biomolecular models that are both physical and performed by computer simulation. Sensor has redefined FCS, creating the first portable, three-channel FCS spectrometer, enabling studies of molecular complexing and interaction at single-molecule levels. The QuantumXpert™ and Sensor’s revolutionary FCSXpert™ software introduce this important single molecule technique into the laboratories of biochemistry and cell and molecular biology in an easy-to-use format.

Applications of this technology have the potential to provide insights that could accelerate the development of new treatments. By integrating this enabling platform with in vivo microscopy techniques, the research teams also seek to advance the field of computer simulation modeling in cancer research and development.

“SAIC-Frederick is very pleased to be collaborating with the science and technology experts at Sensor Technologies. We believe our cooperative efforts to study and integrate leading biomolecular analysis and imaging technologies will result in new insights and analytical approaches to tumor cell biology and function,” said Dr. Stephen Lockett, head of OMAL at SAIC-Frederick.

“Sensor Technologies welcomes the opportunity to bring the detection and measurement capabilities of its FCS platform to bear on the large challenges inherent in understanding the cell biology of cancer and AIDS,” said Dr. David E. Wolf, chief science officer for Sensor Technologies.

In other news, I got a nice “Thank You” letter from what might be the first Job landed because of FredCoBio.  The only problem is that the job was in PG County, but the request came in through the web site, I mailed it out to my “recruiter & hiring managers” mailing list and the person was hired.  Anyone that wants on that list, just let me know.  I’ll be surprised if you’re not on there already.

And don’t forget about NCI’s Seminar series running this month.  I try to post one every month but skipped May.  The seminars are free and open to the public.  This one next week sounds interesting: “Highlights of Thirty-Two Years of Drug Design and Chemistry at the NCI”.  I will try to attend.

And finally I will leave you with a Life Technologies Press release and video:

Invitrogen Scientists Compile Comprehensive Guidebooks for Stem Cell Research
Industry Thought Leaders Edit Two Reference Books Essential for Advancing Regenerative Medicine

CARLSBAD, Calif.–(BUSINESS WIRE)–May. 21, 2009– Invitrogen, a division of Life Technologies Corporation (NASDAQ:LIFE), today announced that four of its scientists whose work is focused in stem cell research are editors of two recently published books that capture many of the latest findings in this field and provide comprehensive guidelines for applying technologies to advance related applications. Emerging Technology Platforms for Stem Cells, by John Wiley & Sons, and Regulatory Networks in Stem Cells, by Springer Science + Business Media are expected to be essential references for researchers, scientists and clinicians applying stem cell science to personalized and regenerative medicine.

Emerging Technology Platforms for Stem Cells was edited by Uma Lakshmipathy, Ph.D., a principal scientist, and lead editor of the book; Jon Chesnut, a research and development director; and Bhaskar Thyagarajan, Ph.D., a program manager, all from Life Technologies. This book presents general principles and methodologies for professionals involved in stem cell research. It focuses on current technologies that can help scientists to overcome some of the challenges they face in developing stem cells as therapeutic agents, incorporating scientific papers by 78 authors from 10 countries.

Regulatory Networks in Stem Cells was edited by Mohan Vemuri, Ph.D., a research and development director at Life Technologies; and by Vinagolu K. Rajasekhar, Ph.D., a senior research scientist, at Memorial Sloane-Kettering Cancer Center in New York. This book describes key factors involved in stem cell pluripotency, maintenance, and directed differentiation towards specific lineages, and how regulation of these complex events results in stem cell fate choices in normal and disease conditions. The book includes writings of 200 authors from around the world.

Uma Lakshmipathy, Ph.D., Principal Scientist, Invitrogen Primary and Stem Cell Systems at Life Technologies

“We think about how technology addresses challenges related to stem cell research daily, and we realized that there are no resources out there – nothing on the market – that describes these emerging technologies and how they will apply to therapy and drug discovery. We wanted a book that would be a window to the future.”

Mohan Vemuri, Ph.D., Research and Development Director, Invitrogen Primary and Stem Cell Systems at Life Technologies

“Regulatory networks are the molecular systems operating at the DNA, RNA and protein levels that play a crucial role in making the stem cells do what they’re supposed to do in normal development, or in cellular repair in disease.”

Additional Resources

Emerging Technology Platforms for Stem CellsOverview, reviews, and order information

Regulatory Networks in Stem CellsOverview, reviews, and order information

Invitrogen Stem Cell Solutions

Invitrogen Leadership in Regenerative Medicine

Invitrogen is a leading provider of platform independent, essential life science technologies for disease and drug research, bioproduction and diagnostics. It is the premier provider of products and services for advancing the field of regenerative medicine. Invitrogen’s efforts are focused on supplying researchers and developers with the most comprehensive suite of products for advancing cell therapy efforts, including the industry’s premier portfolio of tools and reagents for stem cell research. It also focuses on creating unique primary and stem cell models for better and more efficient drug screening. Invitrogen, together with Applied Biosystems ― a global leader in providing innovative instrument systems to accelerate academic and clinical research, drug discovery and development, pathogen detection and forensic DNA analysis ― is part of Life Technologies Corporation, which markets the life science industry’s most comprehensive portfolio of solutions for molecular and cell biology. Invitrogen and Applied Biosystems products are used in nearly every major laboratory in the world.

Posted in Awards and recognition, Business, Events, Funding Available, Government Funded research, Jobs, News, Public/Private Companies, Stem Cells, presentations | Leave a Comment »

Of Morels and Men

Posted by Jim H on May 7, 2009

My interview with the FNP was published yesterday. Published in the “Food” section, no less.  The print edition has  a lot more pictures of my beautiful collection.  Just this goofy picture of me in the on-line version.

Posted in Awards and recognition, Blogterviews, Nature, News | 1 Comment »

Inside the BSL4 facility at NBACC: Popular Science and Social Media

Posted by Jim H on May 5, 2009

I was tipped off on twitter by BioBeers nube @SusanF826 about an article running in Popular Mechanics showing off the insides of the new BL4 facility at NBACC.  Those of you already following me either on FriendFeed or Twitter, this is already old news.  But for those not so early adapters, I think you’ll find it interesting (if you haven’t figured out how to go directly to the link via the hyperlink I inserted above).  The Abstract is rather sensational, but the rest of the article is quite informative.

Left: The air-lock entrance to the lab’s hot zone. Right: A biohazard suit protects Peter Jahrling, chief virus hunter at the Integrated Research Facility in Fort Detrick,

Left: The air-lock entrance to the lab’s hot zone. Right: A biohazard suit protects Peter Jahrling, chief virus hunter at the Integrated Research Facility in Fort Detrick,

Virus Hunters: Inside Maryland’s New Biosafety Level 4 Lab

The swine flu has killed more than a hundred people in Mexico with reports of at least 40 infections in the United States. Could the flu cause a pandemic? Health researchers don’t think so now, but the Center for Disease Control still suggests Americans take precautions by washing hands, covering coughs and staying home if taken ill. Behind closed doors, the NIH continues to study dangerous diseases of all varieties, preparing to stop the next outbreak before it begins. PM got an early inside look at American’s newest infectious disease research laboratory, to see how scientists study the world’s deadliest pathogens.


Rather odd that they’ve tied the H1N1 “pandemic” on this project, as there is no connection what so ever (unless you believe this drivel).  Although there are cooperative arrangements between USAMRIID, NIAID and the CDC, there is not “swine flu” research going on in this facility.  But of course, the consipracy theorists will continue to insists this facility will be the demise of mankind and not play a role in saving it.

Posted in Government Funded research, Vaccines | Leave a Comment »

Spring Research, a Festival at NCI-Frederick, Ft Detrick

Posted by Jim H on May 4, 2009

I had a great time at the Spring Research Festival at Ft Detrick on Thursday.  I posted a quick slide show in YouTube (can’t figure out how to embed the bloody slide shows in WordPress straight from Picasa).

I spent more than half the time walking through the posters.  There must have been at least 200 posters up.  It’s really amazing the research being done there by the various agencies.  I wish I could figure out a way to get it publicized more!  I have been working with Frank at SAIC-Frederick to try and publish more of their press releases, since they are not always picked up by the wire services or local papers.

My slide show features a number of shots of the various infectious disease, vaccine presentations, but there is just as  much, if not more, Cancer & developmental biology stuff.

So we’ll just keep bridging gaps one at a time.

Posted in Academia, Events, Government Funded research, presentations | Leave a Comment »